Jason T Semprini, Caitlin B Biddell, Jan M Eberth, Mary E Charlton, Sarah H Nash, Katherine A Yeager, Donoria Evans, Purnima Madhivanan, Heather M Brandt, Natoshia M Askelson, Aaron T Seaman, Whitney E Zahnd
PURPOSE: By requiring specific measures, cancer endorsements (e.g., accreditations, designations, certifications) promote high-quality cancer care. While 'quality' is the defining feature, less is known about how these endorsements consider equity. Given the inequities in access to high-quality cancer care, we assessed the extent to which equity structures, processes, and outcomes were required for cancer center endorsements. METHODS: We performed a content analysis of medical oncology, radiation oncology, surgical oncology, and research hospital endorsements from the American Society of Clinical Oncology (ASCO), American Society of Radiation Oncology (ASTRO), American College of Surgeons Commission on Cancer (CoC), and the National Cancer Institute (NCI), respectively...
March 20, 2023: Cancer Causes & Control: CCC
Kalyan Sreeram, Randell Seaton, Mark K Greenwald, Mandana Kamgar, Hadeel Assad, Tara Baird, Ann G Schwartz, Julie Ruterbusch, Michael S Simon
PURPOSE: Improved life expectancy has increased the likelihood for long-term complications from chemotherapy among cancer survivors. One burdensome complication is chemotherapy-induced peripheral neuropathy (CIPN). We evaluated rates of CIPN outcomes in the Detroit Research on Cancer Survivorship (ROCS) cohort. METHODS: The population included 1,034 African American (AA) survivors who received chemotherapy for breast, colorectal, lung or prostate cancer. CIPN prevalence was based on initial occurrence of worsening of self-reported pain, numbness or tingling after chemotherapy...
March 19, 2023: Cancer Causes & Control: CCC
Kevin L'Espérance, Anne Grundy, Michal Abrahamowicz, Jocelyne Arseneau, Lucy Gilbert, Walter H Gotlieb, Diane Provencher, Anita Koushik
PURPOSE: To investigate the association between alcohol intake over the lifetime and the risk of overall, borderline, and invasive ovarian cancer. METHODS: In a population-based case-control study of 495 cases and 902 controls, conducted in Montreal, Canada, average alcohol intake over the lifetime and during specific age periods were computed from a detailed assessment of the intake of beer, red wine, white wine and spirits. Multivariable logistic regression was used to estimate odds ratios (ORs) with 95% confidence intervals (CIs) for the association between alcohol intake and ovarian cancer risk...
March 18, 2023: Cancer Causes & Control: CCC
Zeni Wu, Fangyu Li, Jian Sang, Gretchen L Gierach, Emily Vogtmann
PURPOSE: Specific oral health conditions may be risk factors for breast cancer. This study aimed to investigate the associations of oral health conditions with breast cancer risk. METHODS: A total of 234,363 women from the UK Biobank prospective cohort were included in this study. We examined the association of self-reported painful/bleeding gums, loose teeth, mouth ulcers, toothache, and use of dentures with the risk of breast cancer. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) for the associations were calculated with adjustment for multiple confounders...
March 16, 2023: Cancer Causes & Control: CCC
Timothy D Shu, Fredrick R Schumacher, Britt Conroy, Lee Ponsky, Amr Mahran, Laura Bukavina, Adam Calaway, Sarah C Markt
PURPOSE: Previous literature shows that more bladder cancer patients overall die from causes other than the primary malignancy. Given known disparities in bladder cancer outcomes by race and sex, we aimed to characterize differences in cause-specific mortality for bladder cancer patients by these demographics. METHODS: We identified 215,252 bladder cancer patients diagnosed with bladder cancer from 2000 to 2017 in the SEER 18 database. We calculated cumulative incidence of death from seven causes (bladder cancer, COPD, diabetes, heart disease, external, other cancer, other) to assess differences in cause-specific mortality between race and sex subgroups...
March 8, 2023: Cancer Causes & Control: CCC
Laura Berger, Maja Wolf-Breitinger, Christel Weiß, Benjamin Tuschy, Sebastian Berlit, Marc Sütterlin, Saskia Spaich
PURPOSE: According to the recently implemented organized cervical cancer screening program in Germany, women older than 35 years with negative cytology but persistent high-risk human papilloma virus (hrHPV) infection > 12 months should be referred to colposcopy for further evaluation. This study aimed to present and dissect colposcopic and histopathological findings with particular focus on associated hrHPV genotypes. METHODS: This study is a retrospective analysis of clinical data from 89 hrHPV positive patients with normal cytology who underwent colposcopic examination at a certified dysplasia outpatient clinic in Germany in 2021...
February 28, 2023: Cancer Causes & Control: CCC
Adebola Adegboyega, Omoadoni Obielodan, Amanda T Wiggins, Mark Dignan, Lovoria B Williams
BACKGROUND: Despite the disparate human papillomavirus (HPV) infection rates among sexually active Black young adults, HPV vaccine uptake remains low among this population. This study aimed to explore HPV beliefs, attitudes, and knowledge among Black young adults and provide recommendations on ways to improve vaccine uptake. METHODS: We used a mixed-method, convergent design to conduct five focus groups and administered a 40-item electronic survey that was developed with health belief model (HBM) constructs...
February 28, 2023: Cancer Causes & Control: CCC
Maira A Castañeda-Avila, Kathleen M Mazor, Kate L Lapane, Mara M Epstein
PURPOSE: Monoclonal gammopathy of undetermined significance (MGUS) is the precursor of multiple myeloma. This qualitative study described patient (n = 14) experiences and healthcare providers' (n = 8) opinions and practices concerning care for patients with MGUS in the US. METHODS: Semi-structured, in-depth interviews were analyzed using thematic analysis. RESULTS: We identified six overarching themes related to the care pathway for patients with MGUS: (1) Process of MGUS diagnosis, (2) Providers' explanations, (3) Patients' understanding, (4) Impact of the diagnosis, (5) Follow-up/management, and (6) Factors influencing healthcare utilization...
February 28, 2023: Cancer Causes & Control: CCC
Rachel Hirschey, Catherine Rohweder, Whitney E Zahnd, Jan M Eberth, Prajakta Adsul, Yue Guan, Katherine A Yeager, Heidi Haines, Paige E Farris, Jennifer W Bea, Andrea Dwyer, Purnima Madhivanan, Radhika Ranganathan, Aaron T Seaman, Thuy Vu, Karen Wickersham, Maihan Vu, Randall Teal, Kara Giannone, Alison Hilton, Allison Cole, Jessica Y Islam, Natoshia Askelson
PURPOSE: The Centers for Disease Control and Prevention's National Comprehensive Cancer Control Program (NCCCP) requires that states develop comprehensive cancer control (CCC) plans and recommends that disparities related to rural residence are addressed in these plans. The objective of this study was to explore rural partner engagement and describe effective strategies for incorporating a rural focus in CCC plans. METHODS: States were selected for inclusion using stratified sampling based on state rurality and region...
February 25, 2023: Cancer Causes & Control: CCC
Prajakta Adsul, Jessica Islam, Perla Chebli, Julie Kranick, Sarah Nash, Hannah Arem, Stephanie Wheeler, Melissa Lopez-Pentecost, Victoria Foster, Rashmi K Sharma, Tisha Felder, Betsy Risendal, Enmanuel A Chavarria, Simona Kwon, Rachel Hirschey, Chau Trinh-Shevrin
PURPOSE: Although there is national recognition for health equity-oriented research, there is limited guidance for researchers to engage partnerships that promote health equity in cancer research. The Cancer Prevention and Control Research Network's (CPCRN) Health Equity Work Group developed a toolkit to guide researchers in equitable collaborations. METHODS: The CPCRN's Health Equity Work Group collectively outlined health and racial equity principles guiding research collaborations with partners that include communities, community-based organizations, implementing partners in the clinical setting including providers and health care organizations, and policy makers...
February 24, 2023: Cancer Causes & Control: CCC
Mmadili N Ilozumba, Lusine Yaghjyan, Susmita Datta, Jinying Zhao, Chi-Chen Hong, Kathryn L Lunetta, Gary Zirpoli, Elisa V Bandera, Julie R Palmer, Song Yao, Christine B Ambrosone, Ting-Yuan David Cheng
BACKGROUND: Obesity is known to stimulate the mammalian target of rapamycin (mTOR) signaling pathway and both obesity and the mTOR signaling pathway are implicated in breast carcinogenesis. We investigated potential gene-environment interactions between mTOR pathway genes and obesity in relation to breast cancer risk among Black women. METHODS: The study included 1,655 Black women (821 incident breast cancer cases and 834 controls) from the Women's Circle of Health Study (WCHS)...
February 15, 2023: Cancer Causes & Control: CCC
Linnea T Olsson, Carolyn E Eberle, Stacey Petruzella, Whitney R Robinson, Helena Furberg
PURPOSE: Body mass index (BMI) and kidney cancer mortality are inconsistently associated in the scientific literature. To understand how study design affects results, we contrasted associations between pre-diagnosis BMI and mortality under different analytic scenarios in a large, population-based prospective cohort study. METHODS: Using data from the NIH-AARP Diet and Health Study (1995-2011), we constructed two cohorts: a "full at-risk" cohort with no kidney cancer history at baseline (n = 252,845) and an "incident cancer" subset who developed kidney cancer during follow-up (n = 1,652)...
February 14, 2023: Cancer Causes & Control: CCC
Perla Chebli, Prajakta Adsul, Julie Kranick, Catherine L Rohweder, Betsy C Risendal, Emily Bilenduke, Rebecca Williams, Stephanie Wheeler, Simona C Kwon, Chau Trinh-Shevrin
Reflecting their commitment to advancing health equity, the Cancer Prevention and Control Research Network (CPCRN) established a Health Equity Workgroup to identify and distill guiding principles rooted in health equity, community-engaged participatory research (CBPR), social determinants of health, and racial equity frameworks to guide its collective work. The Health Equity Workgroup utilized a multi-phase, participatory consensus-building approach to: (1) identify recurrent themes in health and racial equity frameworks; (2) capture perspectives on and experiences with health equity research among CPCRN members through an online survey; (3) engage in activities to discuss and refine the guiding principles; and (4) collect case examples of operationalizing equity principles in cancer research...
February 14, 2023: Cancer Causes & Control: CCC
Catherine E Slavik, Paul A Demers, Lillian Tamburic, Hunter Warden, Christopher McLeod
PURPOSE: Canada was a major global asbestos producer and consumer. Geographic patterns of Canadian asbestos use and mesothelioma, a highly fatal cancer linked to asbestos exposure, have not been previously reported. This study summarized key trends in mesothelioma incidence by geography and time in two Canadian provinces, Ontario and British Columbia (BC), and explored how past workforce characteristics and geographic trends in asbestos production and use may shape variations in regional rates of mesothelioma...
February 2, 2023: Cancer Causes & Control: CCC
Morgan M Millar, Kimberly A Herget, Blessing Ofori-Atta, Rachel R Codden, Sandra L Edwards, Marjorie E Carter, Brad Belnap, Anne C Kirchhoff, Carol Sweeney
PURPOSE: The 2016-2020 Utah Comprehensive Cancer Prevention and Control Plan prioritized strategies to address cancer survivorship experiences. In this paper we present estimates for nine indicators evaluating these priorities, trends over time, and assess disparities in survivorship experiences across demographic subgroups. METHODS: We surveyed a representative sample of Utah cancer survivors diagnosed between 2012 and 2019 with any reportable cancer diagnosis...
February 1, 2023: Cancer Causes & Control: CCC
Elizabeth J Austin, Mark R Kilgore, Cynthia W Ko, Elizabeth U Parker, Rebeca Alvarez, Lisa K Koch, Amelia W Donlan, Janie M Lee, Meghan R Flanagan, Lauren M DeStefano, Sara H Javid, John L Gore
PURPOSE: New federal legislation in the United States grants patients expanded access to their medical records, making it critical that medical records information is understandable to patients. Provision of informational summaries significantly increase patient perceptions of patient-centered care and reduce feelings of uncertainty, yet their use for cancer pathology is limited. METHODS: Our team developed and piloted patient-centered versions of pathology reports (PCPRs) for four cancer organ sites: prostate, bladder, breast, and colorectal polyp...
January 25, 2023: Cancer Causes & Control: CCC
Asos Mahmood, Satish Kedia, Patrick J Dillon, Hyunmin Kim, Hassan Arshad, Meredith Ray
PURPOSE: To assess the impact of food insecurity on biennial breast cancer screenings (i.e., mammography or breast X-ray) among older women in the United States (US). METHODS: Data from the 2014 and 2016 waves of the Health and Retirement Study and the 2013 Health Care and Nutrition Study were used. The analyses were limited to a nationally representative sample of 2,861 women between 50 and 74 years of age, residing in the US. We employed a propensity score weighting method to balance observed confounders between food-secure and food-insecure women and fit a binary logistic regression to investigate population-level estimates for the association between food security and breast cancer screening...
January 25, 2023: Cancer Causes & Control: CCC
Amy E Leader, Rebecca J Melillo, Quincy Greene, Joshua Blanding-Godbolt, Ayako Shimada, Christine M Eischen, Andrew E Aplin
PURPOSE: Despite the importance of engaging community members in research, multiple barriers exist. We conducted a mixed-methods evaluation to understand the opportunities and challenges of engaging community members in basic, clinical, translational, and population science research. METHODS: We designed a survey and an interview guide based on the constructs of the Consolidated Framework for Implementation Research. Surveys were distributed electronically to all cancer center investigators and interviews were conducted virtually with a select group of basic, clinical, and population science investigators...
January 4, 2023: Cancer Causes & Control: CCC
Pierre Fwelo, David Adzrago, Ayooluwatomiwa D Adekunle, Toluwani E Adekunle, Ambrose Akinlo, William B Perkinson
PURPOSE: Although much emphasis has been placed on the impact of ambiguity on cognitive processes, the impact of mental health disorder symptoms and racial/ethnic disparities in cancer perception of fatalism and ambiguity remains less explored. This study explored the association between mental health disorder symptoms and negative cancer perceptions. Also, we assessed differences in these outcomes within mental health disorder symptoms and racial/ethnic subgroups to investigate the association between cancer perceptions and the other covariates within the aforementioned subgroups...
January 2, 2023: Cancer Causes & Control: CCC
Teoflia Acheampong, Erica J Lee Argov, Mary Beth Terry, Carmen B Rodriguez, Mariangela Agovino, Ying Wei, Shweta Athilat, Parisa Tehranifar
No abstract text is available yet for this article.
December 24, 2022: Cancer Causes & Control: CCC
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.